Results 41 to 50 of about 30,809 (165)
Age and Vasodilator Response to Different Hyperemic Agents: Adenosine versus Contrast Medium
Background: Age-related remodelling has the potential to affect the microvascular response to hyperemic stimuli. However, its precise effects on the vasodilatory response to adenosine and contrast medium, as well as its influence on fractional flow ...
Domenico Galante +18 more
doaj +1 more source
In pulmonary hypertension (PH) associated with chronic lung disease (CLD), identifying patients who would benefit from pulmonary vasodilators is a significant clinical challenge because the presence of PH is associated with poorer survival.
Kenichiro Atsumi +7 more
doaj +1 more source
Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol
Beta-blockers are commonly used medications for cardiovascular diseases. Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification.
Bülent Görenek +7 more
doaj +1 more source
Literature is scarce on acute ischemia after intra-arterial injection of crushed tablets and no effective medical treatment against the progression of lesions is reported.
Grégoire Détriché +16 more
doaj +1 more source
FUNDAMENTO: Os efeitos de longo prazo das drogas desenvolvidas para o controle da hipertensão arterial pulmonar (HAP) são pouco conhecidos, já que os estudos multicêntricos em geral têm duração de 12 a 16 semanas.
Sonia Meiken Franchi +5 more
doaj
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
Interstitial lung diseases (ILDs) encompass a heterogeneous group of over 200 disorders that require individualized treatment. Antifibrotic agents, such as nintedanib and pirfenidone, have remarkably revolutionized the treatment landscape of patients ...
Vito D’Agnano +8 more
doaj +1 more source
To evaluate the chemical reaction of the venous wall to different sclerosing agents, the Authors studied the level of blood histamine concentration before and 8-10 min after sclerotherapy injection into large 3-6 mm subcutaneous varices.
Alessandro Frullini
doaj +1 more source
Objective: To analyse the characteristics, management and outcomes of patients with pulmonary hypertension from a dedicated registry. Method: The retrospective study was conducted at the Pulmonary Hypertension Clinic of the National Institute of ...
Jawed Abubaker +5 more
doaj +1 more source
Background Pulmonary arterial hypertension is a hemodynamic disorder. Signs and symptoms are generally difficult to recognize because they are non-specific. The current treatment for pulmonary arterial hypertension offers no cure or prevention; therefore,
Alan David Kaye +4 more
doaj +1 more source
IntroductionImmune Checkpoint Inhibitors (ICIs) may cause various immune- related Adverse Events (irAEs). Of these events, vascular involvement is still considered an uncommon irAEs and generally concerns large or medium vessels.
Valérian Rivet +8 more
doaj +1 more source

